삼성서울병원

Ko En

병리과 김경미 교수

진료분야
위장관병리, 소화기 병리, 분자병리
진료일정 06 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 07 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
1998.02 가톨릭대학교 대학원 의학과 박사
1994.02 가톨릭대학교 대학원 의학과 석사
1988.02 이화여자대학교 의과대학 의학사
1984.02 이화여자대학교 의예과 수료

경력

경력
2006.02 ~현재 삼성서울병원 병리과 전문의
2006.02 ~현재 성균관대학교 의과대학 병리학교실 교수
2013.09 ~ 2017.03 삼성서울병원 병리과 과장
2003.03 ~ 2006.02 가톨릭대학교 의과대학 병리학교실 부교수
2001.03 ~ 2003.08 University of Southern California 소화기병리 연구원
1998.03 ~ 2003.02 가톨릭대학교 의과대학 병리학교실 조교수
1994.02 ~ 1998.02 가톨릭대학교 의과대학 병리과 전임강사
1990.03 ~ 1994.02 가톨릭대학교 성모병원 레지던트

연구분야

연구분야
위암유전, 위암의 표적치료 타겟 발굴 및 동반진단법 개발
1. 위암은 전세계적으로 암 사망의 두 번째 원인으로, 연간 989,000여 명이 새로 이환되고 738,000여 명이 사망하는 소화기암 분야에서 가장 중요한 관심의 대상임. 위암은 진행된 후 발견되는 경우 고식적 항암치료 시 평균 생존기간은 11-12개월 정도로 예후가 매우 불량함. 2. 위암에서 발견되는 유전자로는 TP53, CDH1, ARID1A, APC, PIK3CA, CTNNB1, KRAS, MSH6 등이 있음. 3. 본 연구자는 PIK3CA가 전이성 진행위암에 흔하고, CTNNB1이 EBV 연관 위암에 흔하며, ROS1-SLC34A2 fusion이 위암에도 존재함을 처음으로 밝힘. 4. 표적 치료제는 기존의 고식적 항암제보다 비교적 부작용이 적은데다, 일부 표적 치료제들은 기존 항암화학요법과 병용 시 생존율을 증가시킨다는 고무적인 연구 결과들이 많이 발표되고 있음. 5. 표적 치료제는 암이 형성되는 과정에 관여하는 특정 표적인자만을 공격하므로 같은 종류의 암이라도 특정 표적인자가 나타나는 환자에게만 효과를 나타냄. 따라서 표적 치료제를 보다 효과적으로 사용하기 위해서는 표적 치료제에 대한 효과를 미리 예측할 수 있는 예측 지표를 정립하는 것이 필요함. 6. 표적 치료제를 사용하였을 때 효과가 높을 가능성이 있는 환자들을 똑바로 선택하는 것은 불필요한 의료비의 지출을 줄이고, 환자에게 나타날 수도 있는 불필요한 부작용을 미리 예방한다는 차원에서도 매우 중요함. 7. 또한 지속적 표적 치료제 투여 시 내성이 생기는 데, 이러한 내성 기전을 규명하고 예방하기 위한 연구가 필요 함. 8. 따라서 본 연구자는 위암 타겟치료의 적응증이 되는 환자를 정확히 찾아내고, 새로운 표적치료 타겟 및 예후인자 발굴, 그리고 동반진단법 개발 등의 연구를 활발히 하고 있음.

학회활동

학회활동
대한암학회 재무이사
Gastric Cancer, Journal of Pathology and Translational Medicine Editorial Board.

수상이력

수상이력
2016.03 보령암학술상 수상
  • Pathology. 2018 Nov 26. pii: S0031-3025(18)30359-3. doi: 10.1016/j.pathol.2018.09.057. [Epub ahead of print] MMR protein immunohistochemistry and microsatellite instability in gastric cancers. Cho J11, Kang SY1, Kim KM2.
    View PubMed
  • Oncotarget. 2018 Feb 9;9(16):12591-12598. doi: 10.18632/oncotarget.24476. eCollection 2018 Feb 27. Peritumoral lymphoid cuff correlates well with lymph node Bae H#11, Van Vrancken M#2, Kang TW3, Park HY4, Chu J1, Park HK1, Ha SY1, Choi D3, Kim KM1.
    View PubMed
  • J Gastroenterol. 2017 May;52(5):594-601. doi: 10.1007/s00535-016-1254-5. Epub 2016 Sep 2. Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis Pyo JH11, Lee H1, Min BH1, Lee JH1, Choi MG2, Lee JH3, Sohn TS2, Bae JM2, Kim KM4, Yeon S5, Jung SH5,6, Kim JJ1, Kim S2.
    View PubMed
  • Gastrointest Endosc. 2017 Apr;85(4):730-736. doi: 10.1016/j.gie.2016.07.046. Epub 2016 Jul 27. One-dimensional and 2-dimensional tumor size measurement for prediction of lymph node metastasis in differentiated early gastric cancer with minute submucosal invasion Kim TJ11, Lee H2, Min YW1, Min BH1, Lee JH1, Kim KM3, Kim MJ4, Kim K4, Rhee PL1, Kim JJ1.
    View PubMed
  • Ann Oncol. 2017 Mar 1;28(3):547-554. doi: 10.1093/annonc/mdw669. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition Kim ST11, Kim SY1, Klempner SJ2,3, Yoon J4, Kim N4, Ahn S4,5, Bang H5,6, Kim KM5,6, Park W4, Park SH1, Park JO1, Park YS1, Lim HY1, Lee SH1, Park K1,6, Kang WK1, Lee J1.
    View PubMed
  • Oncotarget. 2017 Mar 7;8(10):16233-16242. doi: 10.18632/oncotarget.9069. IKK epsilon and TBK1 expression in gastric cancer Lee SE11, Hong M2, Cho J3, Lee J4, Kim KM3.
    View PubMed
  • Oncotarget. 2017 Feb 21;8(8):13320-13328. doi: 10.18632/oncotarget.14519. Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability Cho J11, Lee J2, Bang H3, Kim ST2, Park SH2, An JY4, Choi MG4, Lee JH4, Sohn TS4, Bae JM4, Kang WK2, Kim S4, Kim KM3.
    View PubMed
  • Oncotarget. 2017 Feb 28;8(9):15014-15022. doi: 10.18632/oncotarget.14788. Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion Kim SY11, Ahn T2, Bang H3, Ham JS1, Kim J1, Kim ST1, Jang J1, Shim M1, Kang SY3, Park SH1, Min BH4, Lee H4, Kang WK1, Kim KM3, Park W2,5, Lee J1.
    View PubMed
  • J Cancer. 2017 Feb 25;8(5):730-736. doi: 10.7150/jca.17887. eCollection 2017. An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients Lee JY11, Hong M2, Lee J3, Lee S3, Kim KM2, Park C4, Lim HY3.
    View PubMed
  • Oncotarget. 2017 Jan 10;8(2):3237-3245. doi: 10.18632/oncotarget.13700. The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors Lim SH11, Kim SY1, Kim K2, Jang H1, Ahn S2, Kim KM2, Kim NK3, Park W3, Lee SJ1, Kim ST1, Park SH1, Park JO1, Park YS1, Lee SH1, Lim HY1, Park K1, Kang WK1, Lee J1.
    View PubMed
  • J Mol Diagn. 2017 Jan;19(1):137-146. doi: 10.1016/j.jmoldx.2016.09.006. Epub 2016 Nov 10. Deamination Effects in Formalin-Fixed, Paraffin-Embedded Tissue Samples in the Era of Precision Medicine Kim S11, Park C2, Ji Y3, Kim DG3, Bae H1, van Vrancken M4, Kim DH5, Kim KM6.
    View PubMed
  • Am J Surg Pathol. 2017 Jan;41(1):106-115. High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications Ahn S11, Lee SJ, Kim Y, Kim A, Shin N, Choi KU, Lee CH, Huh GY, Kim KM, Setia N, Lauwers GY, Park DY.
    View PubMed
  • Ann Surg Oncol. 2016 Dec;23(Suppl 5):784-791. Epub 2016 Sep 9. Clinicopathological Features and Prognosis of Mixed-Type T1a Gastric Cancer Based on Lauren's Classification Pyo JH11, Ahn S2,3, Lee H4, Min BH1, Lee JH1, Shim SG5, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim KM2, Yeon S7, Jung SH7,8, Kim JJ9, Kim S6.
    View PubMed
  • Ann Surg. 2016 Dec;264(6):1038-1043. A Risk-prediction Model Based on Lymph-node Metastasis for Incorporation Into a Treatment Algorithm for Signet Ring Cell-type Intramucosal Gastric Cancer Pyo JH11, Shin CM, Lee H, Min BH, Lee JH, Kim SM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim KM, Kim HS, Jung SH, Kim JJ, Kim S; JHP and CMS contributed equally as the first authors of this study..
    View PubMed
  • J Pathol. 2016 Nov;240(3):304-314. doi: 10.1002/path.4777. Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis Min BH11, Hwang J2, Kim NK3, Park G2, Kang SY4, Ahn S4, Ahn S4, Ha SY4, Lee YK4, Kushima R5, Van Vrancken M6, Kim MJ7, Park C2, Park HY2,4, Chae J2, Jang SS2, Kim SJ8, Kim YH1, Kim JI9,10,11, Kim KM12.
    View PubMed
  • J Cancer. 2016 Oct 25;7(15):2173-2178. eCollection 2016. To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients Lee H11, Lee J2, Sohn I3, Park SH2, Park JO2, Park YS2, Kim KM4, Kang WK2, Kim ST2.
    View PubMed
  • Gastric Cancer. 2016 Oct;19(4):1104-13. doi: 10.1007/s10120-015-0570-4. Epub 2015 Nov 30. Pre- and post-ESD discrepancies in clinicopathologic criteria in early gastric cancer: the NECA-Korea ESD for Early Gastric Cancer Prospective Study (N-Keep) Kim JM11, Sohn JH2, Cho MY3, Kim WH4, Chang HK5, Jung ES6, Kook MC7, Jin SY8, Chae YS9, Park YS10, Kang MS11, Kim H12, Lee JH13, Park do Y14, Kim KM15, Kim H12, Kim YW16, Hwang SS17, Seol SY18, Jung HY19, Lee NR20, Park SH20, You JH20.
  • Cancer Res Treat. 2016 Oct;48(4):1155-1166. Epub 2016 Jun 24. Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor Koo DH11,2, Ryu MH2,3, Kim KM2,4, Yang HK2,5, Sawaki A6,7, Hirota S7,8, Zheng J9,10, Zhang B10,11, Tzen CY12, Yeh CN13, Nishida T7,14, Shen L10,15, Chen LT16,17, Kang YK2,3.
    View PubMed
  • Surg Endosc. 2016 Sep;30(9):3987-93. doi: 10.1007/s00464-015-4710-z. Epub 2015 Dec 22. Diagnostic group classifications of gastric neoplasms by endoscopic resection criteria before and after treatment: real-world experience Lee JH11, Min YW1, Lee JH2, Kim ER1, Lee H1, Min BH1, Kim JJ1, Jang KT3, Kim KM3, Park CK3.
    View PubMed
  • Mod Pathol. 2016 Sep;29(9):1095-103. doi: 10.1038/modpathol.2016.96. Epub 2016 May 27. FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival Ahn S11,2, Lee J3, Hong M4, Kim ST3, Park SH3, Choi MG5, Lee JH5, Sohn TS5, Bae JM5, Kim S5, Jung SH6, Kang WK3, Kim KM1,2.
    View PubMed
  • Mol Diagn Ther. 2016 Aug;20(4):375-83. doi: 10.1007/s40291-016-0205-4. A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer Ahn S11,2, Hong M3, Van Vrancken M4, Lyou YJ2, Kim ST5, Park SH5, Kang WK5, Park YS5, Jung SH6, Woo M6, Lee J7, Kim KM8,9.
    View PubMed
  • Clin Cancer Res. 2016 Aug 1;22(15):3831-40. doi: 10.1158/1078-0432.CCR-15-3000. Epub 2016 Mar 1. Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target Yakirevich E11, Resnick MB2, Mangray S2, Wheeler M2, Jackson CL2, Lombardo KA2, Lee J3, Kim KM4, Gill AJ5, Wang K6, Gowen K6, Sun J6, Miller VA6, Stephens PJ6, Ali SM6, Ross JS7, Safran H8.
    View PubMed
  • Mol Diagn Ther. 2016 Aug;20(4):347-51. doi: 10.1007/s40291-016-0203-6. Detecting Primary KIT Mutations in Presurgical Plasma of Patients with Gastrointestinal Stromal Tumor Kang G11, Sohn BS2, Pyo JS3, Kim JY1, Lee B4, Kim KM5.
    View PubMed
  • Oncotarget. 2016 Jul 12;7(28):43492-43503. doi: 10.18632/oncotarget.9523. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis Lee JY11, Lee I2, Chang WJ3, Ahn SM4,5, Lim SH1, Kim HS1, Yoo KH1, Jung KS1, Song HN1, Cho JH1, Kim SY1, Kim KM4,5, Lee S1, Kim ST1, Park SH1, Lee J1, Park JO1, Park YS1, Lim HY1, Kang WK1.
    View PubMed
  • Gastric Cancer. 2016 Jul;19(3):852-9. doi: 10.1007/s10120-015-0524-x. Epub 2015 Aug 12. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma Min BH11, Tae CH1, Ahn SM2, Kang SY2, Woo SY3, Kim S3, Kim KM4.
    View PubMed
  • J Cancer Res Clin Oncol. 2016 Jun;142(6):1231-7. doi: 10.1007/s00432-016-2143-2. Epub 2016 Mar 16. Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin) Kim ST11, Ahn S2, Lee J1, Lee SJ1, Park SH1, Park YS1, Lim HY1, Kang WK1, Kim KM2, Park JO3.
    View PubMed
  • Oncotarget. 2016 May 10;7(19):28670-83. doi: 10.18632/oncotarget.8764. A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth Park J11, Kim SY2, Kim HJ1, Kim KM1,3,4, Choi EY5, Kang MS1,4,5.
    View PubMed
  • PLoS One. 2016 May 26;11(5):e0156207. doi: 10.1371/journal.pone.0156207. eCollection 2016. A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer Pyo JH11, Lee H1, Min BH1, Lee JH1, Choi MG2, Lee JH2, Sohn TS2, Bae JM2, Kim KM3, Ahn HS4, Jung SH4,5, Kim S2, Kim JJ1.
    View PubMed
  • Sci Rep. 2016 May 25;6:26732. doi: 10.1038/srep26732. The minimal amount of starting DNA for Agilent's hybrid capture-based targeted massively parallel sequencing Chung J11,2,3, Son DS1,2, Jeon HJ2, Kim KM4, Park G2, Ryu GH5, Park WY2,3, Park D1,2.
    View PubMed
  • Helicobacter. 2016 Apr;21(2):153-7. doi: 10.1111/hel.12249. Epub 2015 Aug 7. Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer Camargo MC11, Kim KM2, Matsuo K3, Torres J4, Liao LM1, Morgan DR5, Michel A6, Waterboer T6, Zabaleta J7, Dominguez RL8, Yatabe Y9, Kim S10, Rocha-Guevara ER11, Lissowska J12, Pawlita M6, Rabkin CS1.
    View PubMed
  • Oncotarget. 2016 Mar 22;7(12):13797-809. doi: 10.18632/oncotarget.7318. Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation Kim N11,2, Cho A2, Watanabe H3,4, Choi YL2,5, Aziz M6, Kassner M6, Joung JG7, Park AK1,2, Francis JM8, Bae JS7, Ahn SM5, Kim KM5, Park JO9, Park WY2,7, Ahn MJ9, Park K9, Koo J10, Yin HH6, Cho J1,2,7.
    View PubMed
  • Oncotarget. 2016 Feb 9;7(6):6538-51. doi: 10.18632/oncotarget.3731. Integrated genomic analyses identify frequent gene fusion events and VHL inactivation in gastrointestinal stromal tumors Kang G11,2, Yun H1,3, Sun CH3, Park I3, Lee S3, Kwon J3, Do I1,4,5, Hong ME1,5,6, Van Vrancken M1, Lee J7, Park JO7, Cho J8, Kim KM1,5, Sohn TS9.
    View PubMed
  • Sci Rep. 2016 Feb 25;6:22165. doi: 10.1038/srep22165. Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection Xiao H11, Zhang Y2, Kim Y3, Kim S4, Kim JJ5, Kim KM6, Yoshizawa J3, Fan LY1, Cao CX1, Wong DT3.
    View PubMed
  • J Cancer. 2016 Feb 5;7(5):484-9. doi: 10.7150/jca.13711. eCollection 2016. The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs Kim ST11, Ha SY2, Lee S1, Ahn S2, Lee J1, Park SH1, Park JO1, Lim HY1, Kang WK1, Kim KM2, Park YS1.
    View PubMed
  • Oncotarget. 2016 Feb 16;7(7):7940-51. doi: 10.18632/oncotarget.6958. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients Choi HS11,2, Ha SY3, Kim HM1,2, Ahn SM3, Kang MS4,5, Kim KM3, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim S6, Kang ES2.
    View PubMed
  • Am J Gastroenterol. 2016 Feb;111(2):240-9. doi: 10.1038/ajg.2015.427. Epub 2016 Jan 19. Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study Pyo JH11, Lee H1, Min BH1, Lee JH1, Choi MG2, Lee JH2, Sohn TS2, Bae JM2, Kim KM3, Ahn JH4, Carriere KC5, Kim JJ1, Kim S2.
    View PubMed
  • Medicine (Baltimore). 2016 Jan;95(3):e2425. doi: 10.1097/MD.0000000000002425. Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology Lee M11, Chang MY, Shin HY, Shin E, Hong SW, Kim KM, Chay DB, Cho H, Kim JH.
    View PubMed
  • Oncotarget. 2016 Jan 26;7(4):4024-35. doi: 10.18632/oncotarget.6602. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors Park C11, Ha SY1, Kim ST2, Kim HC3, Heo JS3, Park YS2, Lauwers G4, Lee J2, Kim KM1.
    View PubMed
  • Eur J Cancer. 2016 Jan;52:1-9. doi: 10.1016/j.ejca.2015.09.019. Epub 2015 Nov 26. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer Lim SH11, Hong M2, Ahn S3, Choi YL3, Kim KM3, Oh D4, Ahn YC4, Jung SH5, Ahn MJ1, Park K1, Zo JI6, Shim YM6, Sun JM7.
    View PubMed
  • Gut Liver. 2016 Jan;10(1):63-8. doi: 10.5009/gnl14281. Negative Biopsy after Referral for Biopsy-Proven Gastric Cancer Tae CH11,2, Lee JH1, Min BH1, Kim KM3, Rhee PL1, Kim JJ1.
    View PubMed
  • Ann Surg. 2015 Dec;262(6):965-71. doi: 10.1097/SLA.0000000000001039. New 3-Tiered Circumferential Resection Margin Criteria in Esophageal Squamous Cell Carcinoma Lee GD11, Lee SE, Kim KM, Kim YH, Ahn JH, Jung S, Choi YL, Kim HR, Park SI, Shim YM.
    View PubMed
  • Target Oncol. 2015 Dec;10(4):597-601. doi: 10.1007/s11523-015-0361-1. Epub 2015 Mar 5. Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor Kang G11, Bae BN2, Sohn BS3, Pyo JS4, Kang GH5, Kim KM6.
    View PubMed
  • Surg Endosc. 2015 Dec;29(12):3460-8. doi: 10.1007/s00464-015-4095-z. Epub 2015 Feb 12. Clinicopathological factors of multiple lateral margin involvement after endoscopic submucosal dissection for early gastric cancer Lee JH11, Lee JH2, Kim KM3, Kang KJ1, Min BH1, Kim JJ1.
    View PubMed
  • Oncotarget. 2015 Nov 24;6(37):40360-9. doi: 10.18632/oncotarget.5465. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients Kim ST11, Lee WS2, Lanman RB3, Mortimer S3, Zill OA3, Kim KM4,5, Jang KT5, Kim SH5, Park SH1, Park JO1,4, Park YS1, Lim HY1, Eltoukhy H3, Kang WK1, Lee WY6, Kim HC6, Park K1,4, Lee J1,4, Talasaz A3.
    View PubMed
  • Oncotarget. 2015 Nov 17;6(36):39028-35. doi: 10.18632/oncotarget.5494. NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line Lee SJ11, Li GG2, Kim ST1, Hong ME3, Jang J1, Yoon N3, Ahn SM3, Murphy D2, Christiansen J2, Wei G2, Hornby Z2, Lee DW4, Park JO1,5, Park YS1, Lim HY1, Hong SN6, Kim SH3, Kang WK1, Park K1, Park WY7, Kim KM3,5, Lee J1.
    View PubMed
  • Oncotarget. 2015 Nov 10;6(35):38372-80. doi: 10.18632/oncotarget.5368. Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens Ahn S11,2, Ahn S1,3, Van Vrancken M1, Lee M1, Ha SY1, Lee H4, Min BH4, Lee JH4, Kim JJ4, Choi S5, Jung SH5, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim S6, Kim KM1,3.
    View PubMed
  • J Clin Oncol. 2015 Oct 1;33(28):3130-6. doi: 10.1200/JCO.2014.58.3930. Epub 2015 Jan 5. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses Park SH11, Sohn TS1, Lee J1, Lim DH1, Hong ME1, Kim KM1, Sohn I1, Jung SH1, Choi MG1, Lee JH1, Bae JM1, Kim S1, Kim ST1, Park JO1, Park YS1, Lim HY1, Kang WK2.
    View PubMed
  • Medicine (Baltimore). 2015 Oct;94(40):e1622. doi: 10.1097/MD.0000000000001622. Feasibility and Diagnostic Yield of Endoscopic Ultrasonography-Guided Fine Needle Biopsy With a New Core Biopsy Needle Device in Patients With Gastric Subepithelial Tumors Lee M11, Min BH, Lee H, Ahn S, Lee JH, Rhee PL, Kim JJ, Sohn TS, Kim S, Kim KM.
    View PubMed
  • Br J Surg. 2015 Oct;102(11):1394-401. doi: 10.1002/bjs.9873. Epub 2015 Aug 27. Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer Kim ER11, Lee H1, Min BH1, Lee JH1, Rhee PL1, Kim JJ1, Kim KM2, Kim S3.
    View PubMed
  • Oncotarget. 2015 Oct 20;6(32):33358-68. doi: 10.18632/oncotarget.5188. The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis Kim ST11, Lee J1, Hong M2,3, Park K4,5, Park JO1, Ahn T3,4, Park SH1, Park YS1, Lim HY1, Sun JM1, Ahn JS1, Ahn MJ1, Kim HC6, Sohn TS6, Choi DI7, Cho JH8, Heo JS6, Kwon W6, Uhm SW9, Lee H10, Min BH10, Hong SN10, Kim DH5,11, Jung SH12, Park W4,5, Kim KM2,3, Kang WK1, Park K1,2.
    View PubMed
  • Cancer Res Treat. 2015 Oct;47(4):813-22. doi: 10.4143/crt.2014.238. Epub 2015 Feb 26. Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters Gastrointestinal Pathology Study Group of Korean Society of Pathologists1, Sohn JH1, Cho MY2, Park Y3, Kim H4, Kim WH5, Kim JM6, Jung ES7, Kim KM8, Lee JH9, Chan HK10, Park do Y11, Joo M12, Kim S13, Moon WS14, Kang MS15, Jin SY16, Kang YK17, Yoon SO18, Han H19, Choi E20.
    View PubMed
  • Cancer Res Treat. 2015 Oct;47(4):738-46. doi: 10.4143/crt.2014.224. Epub 2015 Feb 16. Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopatholoqical Analysis of 72 Cases in a Single Institute Shin Y11, Ha SY1, Hyeon J1, Lee B1, Lee J2, Jang KT1, Kim KM1, Park YS2, Park CK1.
    View PubMed
  • Oncotarget. 2015 Sep 22;6(28):25619-30. doi: 10.18632/oncotarget.4627. Patient-derived cell models as preclinical tools for genome-directed targeted therapy Lee JY11, Kim SY1, Park C1, Kim NK2, Jang J1, Park K2, Yi JH3, Hong M4,5, Ahn T2, Rath O6, Schueler J6, Kim ST1, Do IG5, Lee S1, Park SH1, Ji YI7, Kim D7, Park JO1,4, Park YS1, Kang WK1, Kim KM4,5, Park WY2,7, Lim HY1, Lee J1,4.
    View PubMed
  • Endoscopy. 2015 Sep;47(9):784-93. doi: 10.1055/s-0034-1392249. Epub 2015 Jun 25. Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer Min BH11, Kim ER1, Kim KM2, Park CK2, Lee JH1, Rhee PL1, Kim JJ1.
    View PubMed
  • Oncotarget. 2015 Sep 29;6(29):28211-22. doi: 10.18632/oncotarget.4721. Gastrointestinal malignancies harbor actionable MET exon 14 deletions Lee J11,2, Ou SH3, Lee JM4, Kim HC5, Hong M6, Kim SY1, Jang J1, Ahn S6, Kang SY6, Lee S1, Kim ST1, Kim B4, Choi J4, Kim KA4, Lee J1, Park C1,6, Park SH1, Park JO1,2, Lim HY1, Kang WK1, Park K1,2, Park YS1, Kim KM2,6.
    View PubMed
  • Oncotarget. 2015 Sep 15;6(27):24320-32. Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening Lee J11, Kim HC2, Hong JY3, Wang K4, Kim SY1, Jang J1, Kim ST1, Park JO1, Lim HY1, Kang WK1, Park YS1, Lee J1, Lee WY2, Park YA2, Huh JW2, Yun SH2, Do IG5, Kim SH5, Balasubramanian S4, Stephens PJ4, Ross JS4,6, Li GG7, Hornby Z7, Ali SM4, Miller VA4, Kim KM5,8, Ou SH9.
    View PubMed
  • PLoS One. 2015 Sep 11;10(9):e0137657. doi: 10.1371/journal.pone.0137657. eCollection 2015. Copy Number Gains at 8q24 and 20q11-q13 in Gastric Cancer Are More Common in Intestinal-Type than Diffuse-Type Jin DH11, Park SE1, Lee J2, Kim KM3, Kim S4, Kim DH1, Park J1.
    View PubMed
  • Transl Oncol. 2015 Aug;8(4):288-94. doi: 10.1016/j.tranon.2015.06.001. Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer Kim ST11, Jang HL2, Lee J1, Park SH1, Park YS1, Lim HY1, Choi MG3, Bae JM3, Sohn TS3, Noh JH3, Kim S3, Kim KM4, Kang WK1, Park JO5.
    View PubMed
  • PLoS Genet. 2015 Aug 21;11(8):e1005467. doi: 10.1371/journal.pgen.1005467. eCollection 2015. Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer Ji JH11, Oh YL2, Hong M2, Yun JW3, Lee HW2, Kim D4, Ji Y4, Kim DH4, Park WY3, Shin HT3, Kim KM2, Ahn MJ5, Park K5, Sun JM5.
    View PubMed
  • Oncotarget. 2015 Aug 21;6(24):20190-203. Overexpression of MAPK15 in gastric cancer is associated with copy number gain and contributes to the stability of c-Jun Jin DH11, Lee J2, Kim KM3, Kim S4, Kim DH1, Park J1.
    View PubMed
  • Gastric Cancer. 2015 Jul;18(3):618-26. doi: 10.1007/s10120-014-0378-7. Epub 2014 May 7. Outcomes of endoscopic submucosal dissection for differentiated-type early gastric cancer with histological heterogeneity Min BH11, Kim KM, Park CK, Lee JH, Rhee PL, Rhee JC, Kim JJ.
    View PubMed
  • Surg Endosc. 2015 Jun;29(6):1614-20. doi: 10.1007/s00464-014-3852-8. Epub 2014 Oct 8. Is endoscopic resection an alternative to surgery for early low-risk submucosal gastric cancers: analysis of a large surgical database Tae CH11, Pouw RE, Duits LC, Sung YK, Min BH, Lee JH, Rhee PL, Kim KM, Bergman JJ, Kim JJ.
    View PubMed
  • Clin Transl Oncol. 2015 Jun;17(6):462-8. doi: 10.1007/s12094-014-1258-7. Epub 2014 Dec 2. The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer Kim ST11, Do IG, Lee J, Sohn I, Kim KM, Kang WK.
    View PubMed
  • Nat Med. 2015 May;21(5):449-56. doi: 10.1038/nm.3850. Epub 2015 Apr 20. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes Cristescu R11, Lee J2, Nebozhyn M1, Kim KM3, Ting JC4, Wong SS4, Liu J4, Yue YG4, Wang J4, Yu K4, Ye XS4, Do IG3, Liu S5, Gong L5, Fu J6, Jin JG6, Choi MG7, Sohn TS7, Lee JH7, Bae JM7, Kim ST2, Park SH2, Sohn I8, Jung SH8, Tan P9, Chen R1, Hardwick J1, Kang WK2, Ayers M1, Hongyue D1, Reinhard C4, Loboda A1, Kim S7, Aggarwal A4.
    View PubMed
  • Int J Cancer. 2015 May 15;136(10):2284-92. doi: 10.1002/ijc.29286. Epub 2014 Nov 6. GAGE12 mediates human gastric carcinoma growth and metastasis Lee EK11, Song KA, Chae JH, Kim KM, Kim SH, Kang MS.
    View PubMed
  • Diagn Pathol. 2015 Apr 30;10:46. doi: 10.1186/s13000-015-0281-5. Exuberant squamous metaplasia of the gastric mucosa in a patient with gastric adenocarcinoma Ahn S11, Bae GE2, Kim KM3.
    View PubMed
  • J Surg Res. 2015 Apr;194(2):458-63. doi: 10.1016/j.jss.2014.12.005. Epub 2014 Dec 8. Lymphoepithelioma-like carcinoma: A distinct type of gastric cancer Park S11, Choi MG2, Kim KM3, Kim HS4, Jung SH4, Lee JH1, Noh JH1, Sohn TS1, Bae JM1, Kim S1.
    View PubMed
  • J Gastrointest Surg. 2015 Apr;19(4):631-8. doi: 10.1007/s11605-014-2708-9. Epub 2014 Dec 4. Preoperative Predictive Factors for Gastrointestinal Stromal Tumors: Analysis of 375 Surgically Resected Gastric Subepithelial Tumors Min YW11, Park HN, Min BH, Choi D, Kim KM, Kim S.
    View PubMed
  • Int J Cancer. 2015 Apr 1;136(7):1568-78. doi: 10.1002/ijc.29133. Epub 2014 Aug 22. Lynch-like syndrome: Characterization and comparison with EPCAM deletion carriers Kang SY11, Park CK, Chang DK, Kim JW, Son HJ, Cho YB, Yun SH, Kim HC, Kwon M, Kim KM.
    View PubMed
  • Int J Cancer. 2015 Apr 1;136(7):1629-35. doi: 10.1002/ijc.29159. Epub 2014 Sep 4. HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: A distinct subset of patients for dual inhibition therapy Ha SY11, Lee J, Jang J, Hong JY, Do IG, Park SH, Park JO, Choi MG, Sohn TS, Bae JM, Kim S, Kim M, Kim S, Park CK, Kang WK, Kim KM.
    View PubMed
  • Sci Rep. 2015 Mar 19;5:9289. doi: 10.1038/srep09289. The Impact of Concomitant Genomic Alterations on Treatment Outcome for Trastuzumab Therapy in HER2-Positive Gastric Cancer Lee JY11, Hong M2, Kim ST1, Park SH1, Kang WK1, Kim KM2, Lee J1.
    View PubMed
  • Gut Liver. 2015 Mar;9(2):202-7. doi: 10.5009/gnl13352. The Role of the CpG Island Methylator Phenotype on Survival Outcome in Colon Cancer Kang KJ11, Min BH2, Ryu KJ2, Kim KM3, Chang DK2, Kim JJ2, Rhee JC2, Kim YH2.
    View PubMed
  • Clin Infect Dis. 2015 Mar 15;60(6):e20-6. doi: 10.1093/cid/ciu969. Epub 2014 Dec 1. Clinical Presentation and Risk Factors for Cytomegalovirus Colitis in Immunocompetent Adult Patients Ko JH11, Peck KR1, Lee WJ1, Lee JY1, Cho SY1, Ha YE1, Kang CI1, Chung DR1, Kim YH2, Lee NY3, Kim KM4, Song JH1.
    View PubMed
  • Gastroenterology. 2015 Jan;148(1):137-147.e9. doi: 10.1053/j.gastro.2014.09.020. Epub 2014 Sep 22. Deregulation of Immune Response Genes in Patients With Epstein-Barr Virus-Associated Gastric Cancer and Outcomes Kim SY11, Park C2, Kim HJ3, Park J1, Hwang J4, Kim JI5, Choi MG6, Kim S6, Kim KM7, Kang MS8.
    View PubMed
  • Eur J Radiol. 2015 Jan;84(1):33-40. doi: 10.1016/j.ejrad.2014.10.020. Epub 2014 Nov 8. Gastrointestinal stromal tumours: Correlation of modified NIH risk stratification with diffusion-weighted MR imaging as an imaging biomarker Kang TW11, Kim SH2, Jang KM1, Choi D1, Ha SY3, Kim KM3, Kang WK4, Kim MJ5.
    View PubMed
  • Ann Oncol. 2015 Jan;26(1):161-6. doi: 10.1093/annonc/mdu504. Epub 2014 Oct 29. Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing Sun JM11, Choi YL2, Ji JH3, Ahn JS1, Kim KM2, Han J2, Ahn MJ1, Park K4.
    View PubMed
  • Asia Pac J Clin Oncol. 2014 Dec;10(4):297-307. doi: 10.1111/ajco.12263. Epub 2014 Sep 16. Human epidermal growth factor receptor 2 testing in gastric cancer: Recommendations of an Asia-Pacific Task Force Kim KM11, Bilous M, Chu KM, Kim BS, Kim WH, Park YS, Ryu MH, Sheng W, Wang J, Chao Y, Ying J, Zhang S.
    View PubMed
  • Sci Rep. 2014 Dec 23;4:7592. doi: 10.1038/srep07592. Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer Yi JH11, Do IG2, Jang J3, Kim ST3, Kim KM4, Park SH3, Park JO3, Park YS3, Lim HY3, Kang WK3, Lee J3.
    View PubMed
  • Mol Cancer Ther. 2014 Nov;13(11):2527-36. doi: 10.1158/1535-7163.MCT-14-0255. Epub 2014 Sep 23. Pazopanib, a Novel Multitargeted Kinase Inhibitor, Shows Potent In Vitro Antitumor Activity in Gastric Cancer Cell Lines with FGFR2 Amplification Kim ST11, Jang HL2, Lee SJ1, Lee J1, Choi YL3, Kim KM3, Cho J4, Park SH1, Park YS1, Lim HY1, Yashiro M5, Kang WK1, Park JO6.
    View PubMed
  • PLoS One.?2014 Nov 5;9(11):e111693. doi: 10.1371/journal.pone.0111693. eCollection 2014. High-Throughput Sequencing and Copy Number Variation Detection Using Formalin Fixed Embedded Tissue in Metastatic Gastric Cancer Kim S11,?Lee J2,?Hong ME3,?Do IG3,?Kang SY1,?Ha SY1,?Kim ST2,?Park SH2,?Kang WK2,?Choi MG4,?Lee JH4,?Sohn TS4,?Bae JM4,?Kim S4,?Kim DH5,?Kim KM3.
    View PubMed
  • Nat Commun. 2014 Nov 19;5:5477. doi: 10.1038/ncomms6477. Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing Wong SS11, Kim KM2, Ting JC1, Yu K1, Fu J3, Liu S4, Cristescu R5, Nebozhyn M5, Gong L4, Yue YG1, Wang J1, Ronghua C5, Loboda A5, Hardwick J5, Liu X5, Dai H5, Jin JG3, Ye XS1, Kang SY2, Do IG2, Park JO6, Sohn TS7, Reinhard C1, Lee J6, Kim S7, Aggarwal A1.
    View PubMed
  • Oncol Lett. 2014 Oct;8(4):1665-1669. Epub 2014 Jul 8. C-KIT-positive undifferentiated tumor of the liver: A case report Chu HH11, Cho BH2, Song JS3, Kim KM4, Moon WS1.
    View PubMed
  • Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1847-53. doi: 10.1007/s10096-014-2107-x. Epub 2014 May 23. Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancer Ko JH11, Peck KR, Lee WJ, Huh K, Yoo JR, Kim K, Cho SY, Ha YE, Kang CI, Chung DR, Jung CW, Kim YH, Lee NY, Kim KM, Song JH.
    View PubMed
  • Dig Dis Sci. 2014 Oct;59(10):2536-43. doi: 10.1007/s10620-014-3196-1. Epub 2014 Aug 9. Endoscopic Resection for Undifferentiated Early Gastric Cancer: Focusing on Histologic Discrepancies Between Forceps Biopsy-Based and Endoscopic Resection Specimen-Based Diagnosis Min BH11, Kang KJ, Lee JH, Kim ER, Min YW, Rhee PL, Kim JJ, Rhee JC, Kim KM.
    View PubMed
  • Clin Radiol. 2014 Aug;69(8):827-35. doi: 10.1016/j.crad.2014.03.017. Epub 2014 May 16. Upper abdominal gadoxetic acid-enhanced and diffusion-weighted MRI for the detection of gastric cancer: Comparison with two-dimensional multidetector row CT Jang KM11, Kim SH2, Lee SJ1, Lee MW1, Choi D1, Kim KM3.
    View PubMed
  • Clin Genet. 2014 Jul;86(1):37-43. doi: 10.1111/cge.12408. Epub 2014 May 10. Innovative personalized medicine in gastric cancer: time to move forward Lee J11, Kim KM, Kang WK, Ou SH.
    View PubMed
  • Am J Surg Pathol. 2014 Jun;38(6):784-92. doi: 10.1097/PAS.0000000000000185. Pyloric Gland Adenoma in Lynch Syndrome Lee SE11, Kang SY, Cho J, Lee B, Chang DK, Woo H, Kim JW, Park HY, Do IG, Kim YE, Kushima R, Lauwers GY, Park CK, Kim KM.
    View PubMed
  • Invest New Drugs. 2014 Jun;32(3):535-41. doi: 10.1007/s10637-014-0065-x. Epub 2014 Jan 28. Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab Lee J11, Hong YS, Hong JY, Han SW, Kim TW, Kang HJ, Kim TY, Kim KP, Kim SH, Do IG, Kim KM, Sohn I, Park SH, Park JO, Lim HY, Cho YB, Lee WY, Yun SH, Kim HC, Park YS, Kang WK.
    View PubMed
  • Ann Surg Oncol. 2014 Apr;21(4):1099-106. doi: 10.1245/s10434-013-3339-1. Epub 2013 Dec 4. CD151 Overexpression is Associated with Poor Prognosis in Patients with pT3 Gastric Cancer Ha SY11, Do IG, Lee J, Park SH, Park JO, Kang WK, Choi MG, Lee JH, Bae JM, Kim S, Kim KM, Sohn TS.
    View PubMed
  • PLoS One. 2014 Mar 5;9(3):e90133. doi: 10.1371/journal.pone.0090133. eCollection 2014. Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery Lee J11, Sohn I2, Do IG3, Kim KM4, Park SH1, Park JO1, Park YS1, Lim HY1, Sohn TS5, Bae JM5, Choi MG5, Lim do H6, Min BH7, Lee JH7, Rhee PL7, Kim JJ7, Choi DI8, Tan IB9, Das K10, Tan P11, Jung SH2, Kang WK1, Kim S5.
    View PubMed
  • World J Gastroenterol. 2014 Feb 7;20(5):1365-70. doi: 10.3748/wjg.v20.i5.1365. Epstein-Barr virus-associated lymphoepithelioma-like early gastric carcinomas and endoscopic submucosal dissection: Case series Lee JY11, Kim KM1, Min BH1, Lee JH1, Rhee PL1, Kim JJ1.
    View PubMed
  • Gut. 2014 Feb;63(2):236-43. doi: 10.1136/gutjnl-2013-304531. Epub 2013 Apr 12. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis Camargo MC11, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R, Meneses-Gonzalez F, Kijima Y, Natsugoe S, Liao LM, Lissowska J, Kim S, Hu N, Gonzalez CA, Yatabe Y, Koriyama C, Hewitt SM, Akiba S, Gulley ML, Taylor PR, Rabkin CS.
    View PubMed
  • Diagn Pathol. 2014 Feb 20;9:34. doi: 10.1186/1746-1596-9-34. Poorly differentiated component in gastric pinch biopsies predicts submucosal invasion Lee SM1, Yang S, Joo M, Kim KM1, Park CK, Ahn S, Min BH, Lee JH, Kim S, Rhee JC, Kim JJ, Lauwers GY.
    View PubMed
  • J Pediatr Hematol Oncol. 2014 Jan;36(1):e61-4. doi: 10.1097/MPH.0b013e31829dd114. Melanotic Neuroectodermal Tumor of Infancy Disseminated by a Ventriculoperitoneal Shunt and Diagnosed from the Inguinal Sac Yoo IH11, Yum SK, Oh SJ, Kim KM, Jeong DC.
    View PubMed
  • Sci Rep. 2014 Jan 10;4:3623. doi: 10.1038/srep03625. Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling Park S11, Lee J1, Do IG2, Jang J2, Rho K3, Ahn S3, Maruja L4, Kim SJ5, Kim KM2, Mao M4, Oh E6, Kim YJ6, Kim J7, Choi YL4.
    View PubMed
  • Mod Pathol.?2013 Dec;26(12):1632-41. doi: 10.1038/modpathol.2013.108. Epub 2013 Jun 28. MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas Ha SY11,?Lee J,?Kang SY,?Do IG,?Ahn S,?Park JO,?Kang WK,?Choi MG,?Sohn TS,?Bae JM,?Kim S,?Kim M,?Kim S,?Park CK,?Ignatius Ou SH,?Kim KM.
    View PubMed
  • Ann Surg Oncol. 2013 Dec;20 Suppl 3:S477-84. doi: 10.1245/s10434-012-2818-0. Epub 2012 Dec 30. A Large Cohort of Consecutive Patients Confirmed Frequent HER2 Positivity in Gastric Carcinomas with Advanced Stages Cho J11, Jeong J, Sung J, Sung CO, Kim KM, Park CK, Choi MG, Sohn TS, Bae JM, Kim S.
    View PubMed
  • PLoS One. 2013 Dec 23;8(12):e82770. doi: 10.1371/journal.pone.0082770. eCollection 2013. Exome Sequencing Identifies Early Gastric Carcinoma as an Early Stage of Advanced Gastric Cancer Kang G11, Hwang WC2, Do IG3, Wang K4, Kang SY3, Lee J5, Park SH5, Park JO5, Kang WK5, Jang J5, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim S6, Kim MJ7, Kim S7, Park CK3, Kim KM3.
    View PubMed
  • PLoS One. 2013 Oct 4;8(10):e77219. doi: 10.1371/journal.pone.0077219. eCollection 2013. GSTT1 Copy Number Gain and ZNF Overexpression Are Predictors of Poor Response to Imatinib in Gastrointestinal Stromal Tumors Lee EJ11, Kang G, Kang SW, Jang KT, Lee J, Park JO, Park CK, Sohn TS, Kim S, Kim KM.
    View PubMed
  • APMIS. 2013 Oct;121(10):938-44. doi: 10.1111/apm.12085. Epub 2013 Jun 12. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic and molecular genetic study of 22 Korean cases Kang G11, Park YS, Jung ES, Joo M, Kang MS, Ahn S, Kang GH, Kim KM.
    View PubMed
  • Korean J Pathol.?2013 Aug;47(4):348-54. doi: 10.4132/KoreanJPathol.2013.47.4.348. Epub 2013 Aug 26. Comparison of Three BRAF Mutation Tests in Formalin-Fixed Paraffin Embedded Clinical Samples Ahn S11,?Lee J,?Sung JY,?Kang SY,?Ha SY,?Jang KT,?Choi YL,?Kim JS,?Oh YL,?Kim KM.
    View PubMed
  • No items found. High Proportion of Granzyme B plus Intraepithelial Lymphocytes Contributes to Epithelial Apoptosis in Helicobacter pylori-Associated Lymphocytic Gastritis
  • Diagn Pathol. 2013 Jul 24;8:121. doi: 10.1186/1746-1596-8-121. Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas Kang SY1, Ahn S, Lee SM, Jeong JY, Sung JY, Oh YL, Kim KM.
    View PubMed
  • Anal Quant Cytopathol Histpathol.?2013 Jun;35(3):146-51. A Comparative Study of Telomerase Activity and Cytologic Diagnosis in Malignant Ascites Park ES11,?Lee J2,?Kang SY3,?Lee EJ1,?Lee MH4,?Yoon N3,?Oh YL3,?Kim KM3.
    View PubMed
  • Korean J Pathol. 2013 Jun;47(3):227-37. doi: 10.4132/KoreanJPathol.2013.47.3.227. Epub 2013 Jun 25. Proposal for a Standardized Pathology Report of Gastroenteropancreatic Neuroendocrine Tumors: Prognostic Significance of Pathological Parameters Gastrointestinal Pathology Study Group of Korean Society of Pathologists1, Cho MY, Sohn JH, Jin SY, Kim H, Jung ES, Kim MJ, Kim KM, Kim WH, Kim JM, Kang YK, Choi JH, Kang DY, Kim YW, Choi EH.
    View PubMed
  • Cancer.?2013 May 1;119(9):1627-35. doi: 10.1002/cncr.27967. Epub 2013 Feb 7. Identification of ROS1 Rearrangement in Gastric Adenocarcinoma Lee J11,?Lee SE,?Kang SY,?Do IG,?Lee S,?Ha SY,?Cho J,?Kang WK,?Jang J,?Ou SH,?Kim KM.
    View PubMed
  • Mod Pathol. 2013 May;26(5):677-84. doi: 10.1038/modpathol.2012.205. Epub 2012 Dec 14. Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas Cho EY11, Park K, Do I, Cho J, Kim J, Lee J, Kim S, Kim KM, Sohn TS, Kang WK, Kim S.
    View PubMed
  • Histol Histopathol. 2013 Apr;28(4):453-62. Epub 2013 Feb 13. Serrated adenoma of the stomach: A clinicopathologic, immunohistochemical, and molecular study of nine cases Kwon MJ11, Min BH, Lee SM, Park HY, Kang SY, Ha SY, Lee JH, Kim JJ, Park CK, Kim KM.
    View PubMed
  • Anal Quant Cytopathol Histpathol. 2013 Feb;35(1):27-35. Heterogeneous Target Protein Expression in Synchronous Multiple Gastric Carcinomas Kang G11, Park HY, Ahn S, Kim KM, Park CK, Choi MG, Sohn TS, Bae JM, Kim S.
    View PubMed
  • J Surg Oncol. 2012 Nov;106(6):757-64. doi: 10.1002/jso.23141. Epub 2012 Apr 25. Tumor size predicts survival in mucinous gastric carcinoma Sung CO11, Lee SM, Choi JS, Kim KM, Choi MG, Noh JH, Sohn TS, Bae JM, Kim WH, Park CK, Kim S.
    View PubMed
  • J Surg Oncol. 2012 Nov;106(6):777-82. doi: 10.1002/jso.23131. Epub 2012 Apr 18. EBV infection and mismatch repair deficiency mediated by loss of hMLH1 expression contribute independently to the development of multiple synchronous gastric carcinomas Park HY11, Kang SY, Kang GH, Bae GE, Lee SE, Kim KM, Park CK, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S.
    View PubMed
  • Endoscopy. 2012 Oct;44(10):949-52. doi: 10.1055/s-0032-1310161. Epub 2012 Sep 17. Gastric extremely well-differentiated intestinal-type adenocarcinoma: a challenging lesion to achieve complete endoscopic resection Kang KJ11, Kim KM, Kim JJ, Rhee PL, Lee JH, Min BH, Rhee JC, Kushima R, Lauwers GY.
    View PubMed
  • Diagn Pathol. 2012 Aug 15;7:102. doi: 10.1186/1746-1596-7-102. Neuroendocrine tumor in gastric adenoma: a diagnostic pitfall mimicking invasive adenocarcinoma Lee SM11, Ahn S, Lee YK, Jang KT, Park CK, Kim KM.
    View PubMed
  • Pathology.?2012 Aug;44(5):460-4. doi: 10.1097/PAT.0b013e3283559c45. Multiplex mutation screening by mass spectrometry in gastrointestinal stromal tumours Kang G11,?Lee J,?Jang KT,?Beadling C,?Corless CL,?Heinrich MC,?Park JO,?Kang WK,?Park CK,?Kim KM.
    View PubMed
  • Korean J Pathol. 2012 Jun;46(3):292-6. doi: 10.4132/KoreanJPathol.2012.46.3.292. Epub 2012 Jun 22. Plexiform Angiomyxoid Myofibroblastic Tumor of the Stomach: Report of Two Cases and Review of the Literature Kang Y11, Jung W, Do IG, Lee EJ, Lee MH, Kim KM, Choi J.
    View PubMed
  • PLoS One.?2012;7(6):e38892. doi: 10.1371/journal.pone.0038892. Epub 2012 Jun 18. High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma Lee J11,?van Hummelen P,?Go C,?Palescandolo E,?Jang J,?Park HY,?Kang SY,?Park JO,?Kang WK,?MacConaill L,?Kim KM.
    View PubMed
  • Pathology. 2012 Jun;44(4):385; author reply 386. doi: 10.1097/PAT.0b013e328353fffe. Filiform serrated adenoma: authors' reply 1,Holck S.
    View PubMed
  • Korean J Pathol. 2012 Jun;46(3):287-91. doi: 10.4132/KoreanJPathol.2012.46.3.287. Epub 2012 Jun 22. Gastric Adenocarcinoma of Fundic Gland Type: Report of Three Cases Park ES11, Kim YE, Park CK, Yao T, Kushima R, Kim KM.
    View PubMed
  • J Korean Med Sci. 2010 Nov;25(11):1543-52. doi: 10.3346/jkms.2010.25.11.1543. Epub 2010 Oct 26. Clinical Practice Guideline for Accurate Diagnosis and Effective Treatment of Gastrointestinal Stromal Tumor in Korea Kang YK11, Kim KM, Sohn T, Choi D, Kang HJ, Ryu MH, Kim WH, Yang HK; Korean GIST Study Group.
    View PubMed
  • Pathology. 2012 Apr;44(3):216-20. doi: 10.1097/PAT.0b013e3283513e8b. Comparison of four immunohistochemical tests and FISH for measuring Her2 expression in gastric carcinomas Cho EY11, Srivastava A, Park K, Kim J, Lee MH, Do I, Lee J, Kim KM, Sohn TS, Kang WK, Kim S.
    View PubMed
  • Acta Oncol. 2012 Apr;51(4):528-36. doi: 10.3109/0284186X.2011.636753. Epub 2011 Dec 7. Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study Kang HJ11, Ryu MH, Kim KM, Park YS, Choi J, Ryoo BY, Kim WH, Im SA, Bang YJ, Park SH, Lee JH, Chung IJ, Bae HI, Kim JG, Lee KH, Song HS, Kwon HC, Baek JH, Shin DB, Lee KE, Kang YK.
    View PubMed
  • Pathology. 2012 Apr;44(3):260-1. doi: 10.1097/PAT.0b013e32834e42f5. Aggressive gastrointestinal stromal tumour of the oesophagus with homozygous KIT exon 11 deletion mutation Cho J1, Kang GH, Kim KM, Park J, Shim YM.
    View PubMed
  • PLoS One.?2012;7(4):e34456. doi: 10.1371/journal.pone.0034456. Epub 2012 Apr 2. Metastasis of Neuroendocrine Tumors Are Characterized by Increased Cell Proliferation and Reduced Expression of the ATM Gene Lee J11,?Sung CO,?Lee EJ,?Do IG,?Kim HC,?Yoon SH,?Lee WY,?Chun HK,?Kim KM,?Park YS.
    View PubMed
  • Pathology. 2012 Jan;44(1):18-23. doi: 10.1097/PAT.0b013e32834d7bbf. Filiform serrated adenoma is an unusual, less aggressive variant of traditional serrated adenoma Ha SY11, Lee SM, Lee EJ, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Kim KM.
    View PubMed
  • Gut Liver. 2012 Jan;6(1):52-7. doi: 10.5009/gnl.2012.6.1.52. Epub 2012 Jan 12. Glomus Tumor of the Stomach: A Clinicopathologic Analysis of 10 Cases and Review of the Literature Kang G11, Park HJ, Kim JY, Choi D, Min BH, Lee JH, Kim JJ, Kim KM, Park CK, Sohn TS, Kim S.
    View PubMed
  • Am J Surg Pathol. 2011 Sep;35(9):1274-86. doi: 10.1097/PAS.0b013e318224cd2e. Molecular Features of Colorectal Hyperplastic Polyps and Sessile Serrated Adenoma/Polyps From Korea Kim KM11, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD.
    View PubMed
  • BMC Cancer. 2011 Aug 10;11:344. doi: 10.1186/1471-2407-11-344. The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy Min BH11, Bae JM, Lee EJ, Yu HS, Kim YH, Chang DK, Kim HC, Park CK, Lee SH, Kim KM, Kang GH.
    View PubMed
  • SSTR2A Protein Expression in Neuroendocrine Neoplasms of the Colorectum
  • Gut Liver. 2011 Jun;5(2):143-8. doi: 10.5009/gnl.2011.5.2.143. Epub 2011 Jun 24. Pathology of Epstein-Barr Virus-Associated Gastric Carcinoma and Its Relationship to Prognosis Song HJ11, Kim KM.
    View PubMed
  • APMIS.?2011 Jun;119(6):330-5. doi: 10.1111/j.1600-0463.2011.02737.x. Epub 2011 Mar 24. KIT amplification and gene mutations in acral/mucosal melanoma in Korea Yun J11,?Lee J,?Jang J,?Lee EJ,?Jang KT,?Kim JH,?Kim KM.
    View PubMed
  • World J Gastroenterol. 2011 Jun 7;17(21):2602-10. doi: 10.3748/wjg.v17.i21.2602. Diagnosis of gastric epithelial neoplasia: Dilemma for Korean pathologists Kim JM11, Cho MY, Sohn JH, Kang DY, Park CK, Kim WH, Jin SY, Kim KM, Chang HK, Yu E, Jung ES, Chang MS, Joo JE, Joo M, Kim YW, Park do Y, Kang YK, Park SH, Han HS, Kim YB, Park HS, Chae YS, Kwon KW, Chang HJ; Gastrointestinal Pathology Study Group of Korean Society of Pathologists.
    View PubMed
  • Mod Pathol. 2011 Jun;24(6):866-75. doi: 10.1038/modpathol.2011.11. Epub 2011 Feb 25. DOG1 and PKC-theta are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors Kang GH11, Srivastava A, Kim YE, Park HJ, Park CK, Sohn TS, Kim S, Kang DY, Kim KM.
    View PubMed
  • Prognostic Significance of Methylation Profiles in Urothelial Carcinomas of the Bladder
  • Pathology. 2010 Dec;42(7):684-6. doi: 10.3109/00313025.2010.523686. Coexistence of EBV associated nasopharyngeal undifferentiated carcinoma and gastric lymphoepithelioma-like carcinoma Lee SM1, Oh YL, Kim KM, Ko YH, Lee J.
    View PubMed
  • Cancer Res Treat. 2012 Jun;44(2):85-96. doi: 10.4143/crt.2012.44.2.85. Epub 2012 Jun 30. Clinical Practice Guideline for Accurate Diagnosis and Effective Treatment of Gastrointestinal Stromal Tumor in Korea Kang YK11, Kang HJ, Kim KM, Sohn T, Choi D, Ryu MH, Kim WH, Yang HK; Korean GIST Study Group (KGSG).
    View PubMed
  • Am J Surg Pathol. 2010 Aug;34(8):1139-46. doi: 10.1097/PAS.0b013e3181e7043b. Micropapillary Carcinoma of Stomach A Clinicopathologic and Immunohistochemical Study of 11 Cases Roh JH11, Srivastava A, Lauwers GY, An J, Jang KT, Park CK, Sohn TS, Kim S, Kim KM.
    View PubMed
  • J Korean Med Sci. 2010 Jun;25(6):853-62. doi: 10.3346/jkms.2010.25.6.853. Epub 2010 May 24. Current Trends in the Epidemiological and Pathological Characteristics of Gastrointestinal Stromal Tumors in Korea, 2003-2004 (vol 25, pg 853, 2010) Cho MY11, Sohn JH, Kim JM, Kim KM, Park YS, Kim WH, Jung JS, Jung ES, Jin SY, Kang DY, Park JB, Park HS, Choi YD, Sung SH, Kim YB, Kim H, Bae YK, Kang M, Chang HJ, Chae YS, Lee HE, Park do Y, Lee YS, Kang YK, Kim HK, Chang HK, Hong SW, Choi YH, Shin O, Gu M, Kim YW, Kim GI, Chang SJ.
    View PubMed
  • Gastroenterology. 2010 Jul;139(1):84-92.e2. doi: 10.1053/j.gastro.2010.04.002. Epub 2010 Apr 14. Host Inflammatory Response Predicts Survival of Patients With Epstein-Barr Virus-Associated Gastric Carcinoma Song HJ11, Srivastava A, Lee J, Kim YS, Kim KM, Ki Kang W, Kim M, Kim S, Park CK, Kim S.
    View PubMed
  • J Korean Med Sci. 2010 Jun;25(6):853-62. doi: 10.3346/jkms.2010.25.6.853. Epub 2010 May 24. Current Trends in the Epidemiological and Pathological Characteristics of Gastrointestinal Stromal Tumors in Korea, 2003-2004 Cho MY11, Sohn JH, Kim JM, Kim KM, Park YS, Kim WH, Jung JS, Jung ES, Jin SY, Kang DY, Park JB, Park HS, Choi YD, Sung SH, Kim YB, Kim H, Bae YK, Kang M, Chang HJ, Chae YS, Lee HE, Park do Y, Lee YS, Kang YK, Kim HK, Chang HK, Hong SW, Choi YH, Shin O, Gu M, Kim YW, Kim GI, Chang SJ.
    View PubMed
  • Am J Surg Pathol. 2010 May;34(5):667-75. doi: 10.1097/PAS.0b013e3181d40cb2. KRAS Mutations in Traditional Serrated Adenomas From Korea Herald an Aggressive Phenotype Kim KM11, Lee EJ, Kim YH, Chang DK, Odze RD.
    View PubMed
  • Gastroenterology. 2010 Jul;139(1):84-92.e2. doi: 10.1053/j.gastro.2010.04.002. Epub 2010 Apr 14. Expression of HSP90 in gastrointestinal stromal tumours and mesenchymal tumours Song HJ11, Srivastava A, Lee J, Kim YS, Kim KM, Ki Kang W, Kim M, Kim S, Park CK, Kim S.
    View PubMed
  • Pathology. 2010 Jan;42(1):54-7. doi: 10.3109/00313020903434413. WT-1 expression in gastrointestinal stromal tumours Kang GH11, Kim KM, Noh JH, Sohn TS, Kim S, Park CK, Lee CS, Kang DY.
    View PubMed
  • Pathology. 2009;41(6):595-6. Microcystic/reticular schwannoma in the colon Lee SM1, Goldblum J, Kim KM.
    View PubMed
  • Pathology. 2009;41(6):593-5. EBV-associated lymphoepithelioma-like gastric carcinoma in a patient with HIV Kim J1, Kim KM, Noh JH, Park CK.
    View PubMed
  • Yonsei Med J. 2009 Oct 31;50(5):709-12. doi: 10.3349/ymj.2009.50.5.709. Epub 2009 Oct 21. Carney Triad in an Adult with Aggressive Behavior: The First Case in Korea Song HJ11, Kim KM, Choi DI, Park CK.
    View PubMed
  • Histopathology. 2009 Sep;55(3):368-9. doi: 10.1111/j.1365-2559.2009.03368.x. PKC-theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumour Kang GH1, Kim KM, Park CK, Kang DY.
    View PubMed
  • Gastrointestinal Stromal Tumor of the Colon Mimicking Inflammatory Fibroid Polyp with a Novel 63 bp c-kit Deletion Mutation - A Case Report
  • Hum Pathol. 2009 Jun;40(6):868-71. doi: 10.1016/j.humpath.2008.11.013. Epub 2009 Mar 9. Mutational analysis of CASP1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 14 genes in gastrointestinal stromal tumors Kim YR11, Kim KM, Yoo NJ, Lee SH.
    View PubMed
  • No items found. Loss of Heterozygosity on Chromosome 15q15 Near Thrombospondin-1 Gene in Breast Carcinomas
  • Mod Pathol. 2009 Feb;22(2):314-20. doi: 10.1038/modpathol.2008.194. Epub 2008 Dec 5. Methylation and API2/MALT1 fusion in colorectal extranodal marginal zone lymphoma Sinn DH11, Kim YH, Lee EJ, Ko YH, Kim KM.
    View PubMed
  • APMIS. 2009 Feb;117(2):87-94. doi: 10.1111/j.1600-0463.2008.00017.x. Prognostic significance of O-6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas Lee SM11, Lee EJ, Ko YH, Lee SH, Maeng L, Kim KM.
    View PubMed
  • Clin Cancer Res. 2009 Jan 1;15(1):291-8. doi: 10.1158/1078-0432.CCR-08-0848. Cyclooxygenase-2 Is an Independent Prognostic Factor in Gastric Carcinoma Patients Receiving Adjuvant Chemotherapy and Is Not Associated with EBV Infection Park ES11, Do IG, Park CK, Kang WK, Noh JH, Sohn TS, Kim S, Kim MJ, Kim KM.
    View PubMed
  • Pathology. 2009;41(4):396-7. doi: 10.1080/00313020902886977. Gastrointestinal stromal tumour with osteoclast-like giant cells and aneurysmal bone cyst-like features Do IG1, Park CK, Kim KM.
    View PubMed
  • Acta Haematol. 2008;120(4):217-24. doi: 10.1159/000195698. Epub 2009 Jan 28. Methylation of p16(INK4A) and Mitotic Arrest Defective Protein 2 (MAD2) Genes in Gastric Marginal-Zone B-Cell Lymphomas Park S11, Kim KM, Kim JJ, Lee JH, Rhee JC, Ko YH.
    View PubMed
  • Pathology. 2008 Oct;40(6):553-7. doi: 10.1080/00313020802320440. Decreased expression of Bax-interacting factor-1 (Bif-1) in invasive urinary bladder and gallbladder cancers Kim SY11, Oh YL, Kim KM, Jeong EG, Kim MS, Yoo NJ, Lee SH.
    View PubMed
  • Ann Surg. 2008 Jun;247(6):1011-8. doi: 10.1097/SLA.0b013e3181724f9d. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy Keun Park C11, Lee EJ, Kim M, Lim HY, Choi DI, Noh JH, Sohn TS, Kim S, Kim MJ, Lee HK, Kim KM.
    View PubMed
  • Pathology. 2008 Jan;40(1):83-5. Metastatic renal cell carcinoma masquerading as a primary gastric carcinoma associated with synchronous early gastric carcinoma Roh JH1, Kim HJ, Jang KT, Kim KM, Kim JJ, Kim S, Park CK.
    View PubMed
  • APMIS. 2007 Aug;115(8):982-6. Deletion mutation of BRAF in a serrated adenoma from a patient with familial adenomatous polyposis Lee EJ11, Park CK, Kim JW, Chang DK, Kim KM.
    View PubMed
  • Histopathology. 2007 Jul;51(1):116-9. Epub 2007 May 31. Localized gastric crystal-storing histiocytosis Joo M1, Kwak JE, Chang SH, Kim H, Chi JG, Moon YS, Kim KM.
    View PubMed
  • Eur J Haematol. 2007 Jul;79(1):86-7. Epub 2007 May 28. Absence of CASP7 and CASP8 mutation in gastrointestinal lymphomas Yoo NJ1, Soung YH, Lee SH, Kim KM, Lee SH.
    View PubMed
  • APMIS. 2007 Jun;115(6):713-8. AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas Cho EY11, Kim KM, Park CK, Kim JJ, Sohn TS, Kim DW.
    View PubMed
  • J Pediatr Hematol Oncol. 2007 Jun;29(6):412-5. Aggressive systemic mastocytosis after germ cell tumor of the ovary - C-KIT mutation documentation in both disease states Lee JW11, Yang WS, Chung SY, Kang JH, Cho B, Kim HK, Kim KM, Jeong DC.
    View PubMed
  • Am J Surg Pathol. 2007 Feb;31(2):224-32. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients Kang DY11, Park CK, Choi JS, Jin SY, Kim HJ, Joo M, Kang MS, Moon WS, Yun KJ, Yu ES, Kang H, Kim KM.
    View PubMed
  • J Korean Med Sci. 2007 Feb;22(1):63-9. Helicobacter heilmannii-associated gastritis: Clinicopathologic findings and comparison with Helicobacter pylori-associated gastritis Joo M11, Kwak JE, Chang SH, Kim H, Chi JG, Kim KA, Yang JH, Lee JS, Moon YS, Kim KM.
    View PubMed
  • Breast Cancer Res Treat. 2006 Aug;98(3):337-42. Epub 2006 Feb 24. Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer Park K11, Han S, Gwak GH, Kim HJ, Kim J, Kim KM.
    View PubMed